Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 499 entries
View as:

Positron Emission Tomography for Detecting Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004138 Org: User:
Start: 09/30/99 End: 12/31/02 Due: 12/31/03

Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003351 Org: User:
Start: 08/31/98 End: 10/31/06 Due: 10/31/07

Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00513747 Org: User:
Start: 01/31/08 End: 06/30/16 Due: 06/30/17

Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01041781 Org: User:
Start: 02/28/10 End: 03/31/18 Due: 03/31/19

Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00091247 Org: User:
Start: 12/31/04 End: 07/31/09 Due: 07/31/10

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00049127 Org: User:
Start: 06/30/03 End: 09/01/19 Due: 09/01/20

Methylphenidate in Treating Patients With Fatigue Caused by Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00376675 Org: User:
Start: 02/29/08 End: 06/30/10 Due: 06/30/11

Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202

Phase: N/A Priority: Normal
NCT ID: NCT01503619 Org: User:
Start: 01/31/12 End: 02/27/19 Due: 02/27/20

Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Phase: N/A Priority: Normal
NCT ID: NCT00022139 Org: User:
Start: 01/31/02 End: 01/31/09 Due: 01/31/10

Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00024102 Org: User:
Start: 09/30/01 End: 11/30/12 Due: 11/30/13

Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00043069 Org: User:
Start: 11/30/02 End: 01/31/10 Due: 01/31/11

Epoetin Alfa in Treating Anemia in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00058331 Org: User:
Start: 06/30/03 End: 05/31/06 Due: 05/31/07

Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02749903 Org: User:
Start: 06/30/16 End: 07/05/22 Due: 07/05/23

Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107

Phase: N/A Priority: Normal
NCT ID: NCT00898547 Org: User:
Start: 11/30/05 End: 08/31/15 Due: 08/31/16

Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission

Phase: N/A Priority: Normal
NCT ID: NCT00070135 Org: User:
Start: 01/31/04 End: 06/15/16 Due: 06/15/17

Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00898092 Org: User:
Start: 05/31/06 End: - Due: -

Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function

Phase: N/A Priority: Normal
NCT ID: NCT00002624 Org: User:
Start: 12/31/94 End: 08/31/05 Due: 08/31/06

Irinotecan and Cetuximab in Treating Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00275041 Org: User:
Start: 02/28/06 End: 02/28/09 Due: 02/28/10

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

Phase: N/A Priority: Normal
NCT ID: NCT05379153 Org: User:
Start: 12/31/24 End: 05/31/27 Due: 05/31/28

Home-Based Programs for Improving Sleep in Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00993928 Org: User:
Start: 04/30/10 End: 05/01/19 Due: 05/01/20

Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00002676 Org: User:
Start: 07/31/95 End: 10/31/06 Due: 10/31/07

Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00826540 Org: User:
Start: 09/30/09 End: 02/28/14 Due: 02/28/15

Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00041119 Org: User:
Start: 05/31/02 End: 06/30/14 Due: 06/30/15

Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00265733 Org: User:
Start: 02/28/06 End: 05/31/13 Due: 05/31/14

Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00003863 Org: User:
Start: 06/30/99 End: 05/31/05 Due: 05/31/06